Click here to view video highlights from this interview. AJMC ®: What stands out in the 2022 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Failure Society of America ...

Please provide your email address to receive an email when new articles are posted on . In this video, Lynne Warner Stevenson, MD, discusses new guidelines regarding the use of SGLT2 inhibitors from ...

Case demonstrates initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor in a patient with type 2 diabetes and heart failure. A 56-year-old man with a history of hypertension and type 2 ...

Earlier this year, empagliflozin (Jardiance) won FDA approval for a broader indication in heart failure across the spectrum of ejection fraction. As part of our review of the year's top stories, we ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

A new joint guideline published today from the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America, increases the focus on preventing heart failure ...

Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ...

Please provide your email address to receive an email when new articles are posted on . Patients with heart failure who received an SGLT2 inhibitor were less likely to experience sudden cardiac death ...

Some heart failure patients had arguably better outcomes after simultaneous initiation of an SGLT2 inhibitor plus a mineralocorticoid receptor antagonist (MRA) in the SOGALDI-PEF trial, but safety ...

The new guidelines also call for better incorporation and addressing of social determinants of health. During a panel at the American College of Cardiology’s (ACC) 70th Scientific Session, experts ...

People with symptomatic heart failure may be able to reduce their risk of premature death by taking a drug originally designed for type 2 diabetes, according to new treatment guidelines from the ...